AstraZeneca and Merck Rapidly Advance LYNPARZA in Japan With a Second Regulatory Submission
AstraZeneca and Merck , known as MSD outside the U.S. and Canada, announced that they have submitted a NDA to...
AstraZeneca and Merck , known as MSD outside the U.S. and Canada, announced that they have submitted a NDA to...
Mylan N.V. announced that the United Kingdom's High Court of Justice has issued a decision in favor of Mylan and...
Avella announced that it has been selected by AstraZeneca to distribute CALQUENCE® , a Bruton tyrosine kinase (BTK) inhibitor indicated...
Alopexx Vaccine LLC announced that it has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly...
In this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who...
Allergan plc presented new analyses of VENUS II, the second of two pivotal Phase 3 clinical trials evaluating the efficacy...
Irvine Scientific, a world leader in the innovation, development, and manufacture of Assisted Reproductive Technologies (ART), announced a new agreement...
Arrakis Therapeutics, a pioneering biopharmaceutical company announced that it has released SHAPEware™ as open-source software for the research community with...
Catalent, Inc , the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health...
Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. FDA approval on its ANDA for a...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.